Knowing how much BCG Vaccine treatment for success rate of bladder cancer, it is a vaccine used as the main therapy for patients with bladder cancer. Bladder cancer is a type or type of cancer that starts from the bladder, the organ that is used as a place to store urine. BCG immunization is one method of bladder cancer treatment.
The success rate of BCG treatment for success rate of bladder cancer is a quite high percentage, which is 65 percent in fifteen years. Bladder cancer patients have symptoms of blood in the urine that is usually accompanied by pain. In addition to the pain and blood in the urine, bladder cancer can spread to the muscles around the bladder.
BCG Vaccine Mechanism in Bladder Cancer Patients
- Bladder cancer is a type of cancer that is often cured using BCG vaccine.
- The BCG vaccine will be active if the bladder cancer patient needs to do the immunocompetent or produce a normal immune response, eating the tumor burden should be small, direct contact with the tumor should occur, and appropriate dosing to give or affect the form of reacting.
- BCG treatment for bladder cancer success rate is able to destroy cancer up to 70 percent of patients.
For those of you who want to prevent bladder cancer in order not to recur again, please do long-term therapy. I recommend that treatment with BCG vaccine be done weekly for the first six weeks. Then, the next six weeks you need to do if the results of cystoscopy show the tumor is still recurring. Therapy using BCG vaccine every week for three weeks, in six months, for one to three years will provide maximum results against bladder cancer patients.
Giving BCG Vaccine Treatment for A Success Rate of Bladder Cancer
To reduce BCG vaccine should be given slowly and repeatedly. Often the time is taken to deliver BCG vaccine to bladder cancer patients slowly as an induction phase, i.e. every week for six weeks or one month over two weeks.
BCG treatment for the success rate of bladder cancer can be given more or less, depending on the sufferer. Often BCG vaccine is given slowly, doctors should assess the response of bladder cancer patients. The induction phase is declared complete if an immunological reaction has occurred. Signs of the emergence of immunological reactions are patients experiencing irritation symptoms in the bladder, microscopic hematuria appears to appear, and urine contains leukocytes or white blood cells when not infected. BCG solution can be prepared by dissolving the frozen powder and dry powder using diluent. This solution is then diluted again using salt until its total volume is 30 mL. this treatment or medication is not the best, but surely you have to try since it has 65 percent of success rate. BCG treatment for success rate of bladder cancer is relatively high.